HIGHLIGHTS
- who: Hristos Karakizlis and colleagues from the peritoneal dialysis) at the University Hospital Giessen and Marburg, Giessen, Germany [1]We assessed anti-SARS-Co, spike antibodies using a dot plot array (GenID, Strassberg, Germany) and chemiluminescent micropArticle immunoassay (Anti-S AdviseDx anti-SARS-Co, spike antibodies II, Abbott, Chicago, IL, USA), and, cell responses by interferon (IFN)-γ and interleukin (IL), peripheral blood leukocyte secretion upon SARS-Co, glycoprotein stimulation (ELISpot assay, GenID have published the research: RESEARCH LETTER Humoral and cellular immune_responses to the mRNA‑1273 SARS‑CoV‑2 vaccine booster in patients on maintenance dialysis, in . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.